Sydney announced as host location for AusMedtech 2025


AusBiotech is bringing Australia’s premier medical technology event, AusMedtech, to Sydney, New South Wales, in 2025 – the first time the conference has ever been held in the state.

As the flagship event of Australia’s biggest week in medtech, the AusMedtech 2025 national conference will be hosted in NSW from 7-8 May at the ICC Sydney.

AusMedtech attracts more than 450 medical technology developers and professionals from across Australia and overseas, bringing the ecosystem together to discuss the latest medtech advancements and trends impacting the sector.

Running in its eighteenth year, AusMedtech 2025’s two-day programme will include:

  • Cutting-edge insights: Building upon the success of previous years, AusMedtech 2025 offers a dynamic programme featuring 70+ thought-provoking keynotes and expert talks led by industry leaders. Explore a diverse range of topics, including Australian success stories, manufacturing, overcoming distribution challenges, advancements in diagnostics, and emerging technologies from Australia’s innovators.
  • Networking opportunities: Engage with industry leaders and potential partners through our exclusive AusPartnering business matching app. AusMedtech provides an ideal platform to exchange ideas, foster collaborations, and connect with like-minded professionals passionate about driving innovation in healthcare. Take advantage of the networking functions including the Welcome Reception, AusMedtech Conference Dinner, Closing Reception, and catering breaks in the Exhibition Hall.
  • Inspiring keynotes: Be inspired by our lineup of keynote speakers as they share fresh insights into the latest advancements shaping the future of healthcare technology.
  • Interactive panels: Participate in 25+ interactive panel discussions addressing key topics such as fostering innovation, the role of incubators and accelerators in medtech, waste and sustainability, and navigating regulatory and reimbursement landscapes. Learn from experts who have successfully navigated the intricacies of the industry.
  • Early-Stage Innovation Forum: Discover and support early-stage innovators with presentations from Australia's local research institutes, universities, hospitals, and pre-series A companies on emerging early-stage technologies, as they gather feedback from experts to support their commercialisation journey.
  • Clinical Trials Dinner: Join industry peers for an informal dinner to celebrate the progress of the clinical trials sector and connect face-to-face before the official start of AusMedtech 2025.
  • Site tours: Explore New South Wales’ vibrant life sciences ecosystem, and check out Australia’s world-class infrastructure via tours of key life science precincts, businesses, and more. More information to come.

AusMedtech is created by industry, for industry. Themes explored in the program include workforce capabilities, intellectual property (IP), capital markets, market access, clinical trials, and manufacturing.

Australia’s life science ecosystem has experienced strong growth over the past five years. As revealed in AusBiotech-commissioned research, the sector is rapidly expanding, with 50 per cent growth between 2019 and 2022, for the first time exceeding the number of therapeutic companies developing life-enhancing and life-saving technologies in Australia. 

AusBiotech will call for AusMedtech 2025 programme session ideas in November this year. Sign up here to receive email updates on AusBiotech events.

Further conference details can be found on the AusMedtech website.

AusMedtech 2025 is supported by its host state partners, the New South Wales Government, Investment NSW, and the AusMedtech programme committee.